DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Robu S, Schmidt A, Eiber M. et al.
Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007.
EJNMMI Res 2018;
8 (01) 30
DOI: 10.1186/s13550-018-0382-8. (PMID: 29651565)
We do not assume any responsibility for the contents of the web pages of other providers.